Hoosier Cancer Research Network Chairman Christopher A. Fausel, PharmD, has again and again raised the bar in the fight against cancer – literally. This spring, he reissued his unique challenge to friends and supporters of HCRN: the Reps for Research challenge. Combining his interest in strength training and his passion for investigator-initiated research, Fausel invited pledges for every bench-press “rep” he could complete at the Arnold Sports Festival’s 5K Pump and Run event in Columbus, Ohio.
“Each repetition generates a donation to the fund of the Hoosier Cancer Research Network,” said Fausel. At the largest event of its kind and flanked by competitors from across the country, Fausel lifted up more than weights, but also the cause of innovative clinical trials in oncology. “We are looking to partner with physicians, not only in Indiana, but throughout the United States, to come up with really important clinical studies for many different types of cancer research.”
Fausel met his goal of 30 reps – the maximum set by the Pump and Run event. Twenty-three donors pressed over $3,000 of combined rep-based and non-rep-based donations.
“Gifts that you have given for this organization help us provide a broader scope in terms of the research opportunities that we offer cancer patients, not only in the state of Indiana, but throughout the whole United States,” said Fausel. “So, thank you very much. We appreciate your support.”
About Hoosier Cancer Research Network:
Hoosier Cancer Research Network (formerly known as Hoosier Oncology Group) conducts innovative cancer research in partnership with academic and community physicians and scientists across the United States and internationally. The organization provides comprehensive clinical trial management and support, from conception through publication. Created in 1984 as a program of the Walther Cancer Institute, Hoosier Cancer Research Network became an independent nonprofit clinical research organization in 2007. Since its founding, Hoosier Cancer Research Network has initiated more than 160 trials in a variety of cancer types and supportive care, resulting in more than 300 publications. More than 5,000 subjects have participated in Hoosier Cancer Research Network clinical trials.
